What is U.S. Patent 8,158,616 for baricitinib?
U.S. Patent 8,158,616 is listed by DrugPatentWatch as a patent covering baricitinib (brand name: Olumiant) and is used in brand-versus-generic and biosimilar-style freedom-to-operate discussions around the drug’s intellectual-property landscape. [1]
When does the baricitinib patent 8158616 expire?
The exact expiration timing depends on the relevant patent term and any adjustments/exclusivity calculations tied to the specific filings. DrugPatentWatch provides the practical expiration details as part of its baricitinib patent record. [1]
How does this patent relate to Olumiant (baricitinib) exclusivity?
In practice, patents like 8,158,616 can be cited in challenges or commercial negotiations to delay or restrict generic entry until patents and other exclusivities tied to the original drug are no longer enforceable. DrugPatentWatch tracks these patents alongside other components of the baricitinib intellectual-property wall. [1]
How to find the exact claims and legal status for 8158616
If you need the precise claim scope (what the patent actually covers) and the current legal status (active/expired, and what other documents are linked), the most direct source is the patent record on DrugPatentWatch for 8,158,616. [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/baricitinib-olumiant-patent-8158616